Indexed keywords
GAG PROTEIN;
PLASMID DNA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CD4+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
DNA IMMUNIZATION;
ELECTROPORATION;
ENZYME LINKED IMMUNOSPOT ASSAY;
FEMALE;
FLOW CYTOMETRY;
GENE EXPRESSION;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
MOUSE;
NONHUMAN;
VACCINATION;
ANIMALS;
CD4-POSITIVE T-LYMPHOCYTES;
CYTOKINES;
ELECTROPORATION;
FEMALE;
GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;
GENETIC VECTORS;
HIV-1;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNITY, HUMORAL;
INJECTIONS, INTRAMUSCULAR;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
PLASMIDS;
SKIN;
SPLEEN;
VACCINATION;
VACCINES, DNA;
HUMAN IMMUNODEFICIENCY VIRUS;
1
52449104809
DNA vaccines: Readyfor primetime?
Kutzler MA, Weiner DB. DNA vaccines: Readyfor primetime? Nat Rev Genet 2008; 9: 776-788.
(2008)
Nat Rev Genet
, vol.9
, pp. 776-788
Kutzler, M.A.1
Weiner, D.B.2
2
0347286952
Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin
DOI 10.1016/j.ymthe.2003.09.008
Babiuk S, Baca-Estrada ME, Foldvari M, Baizer L, Stout R, Storms M et al. Needle-Free topical electroporation improves gene expression from plasmids administered in porcineskin. Mol Ther 2003; 8: 992-998. (Pubitemid 38072312)
(2003)
Molecular Therapy
, vol.8
, Issue.6
, pp. 992-998
Babiuk, S.1
Baca-Estrada, M.E.2
Foldvari, M.3
Baizer, L.4
Stout, R.5
Storms, M.6
Rabussay, D.7
Widera, G.8
Babiuk, L.9
3
30344433748
Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation
DOI 10.1016/j.ymthe.2005.08.005, PII S1525001605015583
Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immuneresponseto a prostatecancer DNA vaccineby intradermal electroporation. Mol Ther 2006; 13: 320-327. (Pubitemid 43056897)
(2006)
Molecular Therapy
, vol.13
, Issue.2
, pp. 320-327
Roos, A.-K.1
Moreno, S.2
Leder, C.3
Pavlenko, M.4
King, A.5
Pisa, P.6
4
33846593511
Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge
DOI 10.1016/j.vaccine.2006.11.017, PII S0264410X06012023
Hooper JW, Golden JW, Ferro AM, King AD. Smallpox DNA vaccine delivered by novel skin electroporation device protects miceagainst intranasal poxviruschallenge. Vaccine 2007; 25:1814-1823. (Pubitemid 46176327)
(2007)
Vaccine
, vol.25
, Issue.10
, pp. 1814-1823
Hooper, J.W.1
Golden, J.W.2
Ferro, A.M.3
King, A.D.4
5
37549037877
Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques
Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 2008; 26: 440-448.
(2008)
Vaccine
, vol.26
, pp. 440-448
Hirao, L.A.1
Wu, L.2
Khan, A.S.3
Satishchandran, A.4
Draghia-Akli, R.5
Weiner, D.B.6
6
0034990926
Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization
DOI 10.1006/mthe.2000.0257
Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneous trans-fection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001; 3: 249-255. (Pubitemid 32509828)
(2001)
Molecular Therapy
, vol.3
, Issue.2
, pp. 249-255
Drabick, J.J.1
Glasspool-Malone, J.2
Somiari, S.3
King, A.4
Malone, R.W.5
7
41149096579
T-cell quality in memory and protection: Implications for vaccine design
DOI 10.1038/nri2274, PII NRI2274
Seder RA, Darrah PA, Roederer M. T-Cell quality in memory and protection: Implica-tions for vaccine design. Nat Rev Immunol 2008; 8: 247-258. (Pubitemid 351432801)
(2008)
Nature Reviews Immunology
, vol.8
, Issue.4
, pp. 247-258
Seder, R.A.1
Darrah, P.A.2
Roederer, M.3
8
69949121286
Optimization of skin electroporation in miceto increasetolerability of DNA vaccinedelivery to patients
Roos AK, Eriksson F, Walters DC, Pisa P, King AD. Optimization of skin electroporation in miceto increasetolerability of DNA vaccinedelivery to patients. Mol Ther 2009; 17: 1637-1642.
(2009)
Mol Ther
, vol.17
, pp. 1637-1642
Roos, A.K.1
Eriksson, F.2
Walters, D.C.3
Pisa, P.4
King, A.D.5